Cancer factsheet: female breast. by unknown
  Family history 
 Nulliparity and low parity 
 Late age first pregnancy 
 Late natural menopause 
 Late menarche 
 Oral contraceptives 
 Diethylstilbestrol 
 Greater body fatness 
 Alcohol 
 Smoking 
 Ionizing radiation 
 Benign breast disease 









Age profile at diagnosis and death 
Top risk factors 
































 Invasive Insitu 
Number of new cases per year 2919 357 
     Incidence rate (cases per 100,000 per year) 121.6 16.0 
     Cumulative lifetime risk of diagnosis (to age 74) 1 in 11 1 in 76 
     Percentage of all invasive cancers * 30.1% - 
     Ranking among most common cancers * 1st - 
Number of deaths per year 694 - 
     Mortality rate (deaths per 100,000 per year) 26.6 - 
     Cumulative lifetime risk of death (to age 74) 1 in 50 - 
     Percentage of all cancer deaths 17.1% - 
     Ranking among most common invasive cancer deaths 2nd - 
Number of people with this cancer still alive, end 2014 # 31457 3672 
     Number alive per 100,000 1350 158 
*invasive cancers only, excluding non-melanoma skin cancer 
# diagnosed since 1994 
Median age group=60-64 Median age group=70-74 
Annual average number of cases, 2005-2014: 
colours indicate higher or lower than 
expected based on national rates 
% of all cases diagnosed 2012-2014 
 
Information on cancer mortality provided by the Central 
Statistics Office. Incidence: 2012-2014 and mortality: 
2011-2013 averages unless otherwise stated 
Last updated May 2017 © 
National Cancer Registry, 
Ireland 
APC# Incidence invasive: (94-02) 2.8%, (02-05) -1.8%, (05-08) 5.7%, (08-14) -1.1% 
          Insitu: (94-06) 8.5%, (06-09) 18.3%, (09-14) -0.4% 
          Mortality: (94-13) -1.9% 
# Annual Percentage Change 
Treatment within 1 year 5 year net survival 



































































































































































1994-1998 71.6% 70.0-73.1% 
1999-2003 77.3% 75.9-78.6% 
2004-2008 80.8% 79.6-82.0% 
2009-2013 83.1% 81.5-84.5% 
 
*10 year net survival (hybrid analysis): 
  75.1% (73.1-77.2%) 
99% pathologically 
diagnosed 
Female breast 
